Vorapaxar | hsa00220 | Arginine biosynthesis | 2.86E-02 | 2 | P15104, P05089 | GLUL, ARG1 | More | |
Vorapaxar | hsa00240 | Pyrimidine metabolism | 4.29E-02 | 2 | P21589, P04183 | NT5E, TK1 | More | |
Vorapaxar | hsa00310 | Lysine degradation | 7.78E-05 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | |
Vorapaxar | hsa00513 | Various types of N-glycan biosynthesis | 4.96E-02 | 1 | Q9NR34 | MAN1C1 | More | |
Vorapaxar | hsa00515 | Mannose type O-glycan biosynthesis | 2.43E-03 | 1 | O75072 | FCMD | More | |
Vorapaxar | hsa00564 | Glycerophospholipid metabolism | 4.29E-02 | 2 | Q6P1A2, P23743 | MBOAT5, DGKA | More | |
Vorapaxar | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Vorapaxar | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | |
Vorapaxar | hsa00620 | Pyruvate metabolism | 9.34E-04 | 2 | P40925, P51648 | MDH1, ALDH3A2 | More | |
Vorapaxar | hsa00630 | Glyoxylate and dicarboxylate metabolism | 5.60E-06 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Vorapaxar | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Vorapaxar | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Vorapaxar | hsa03040 | Spliceosome | 5.98E-06 | 6 | O60508, P26368, Q01130, Q13243, P11142, O43447 | CDC40, U2AF2, SFRS2, SFRS5, HSPA8, PPIH | More | |
Vorapaxar | hsa03450 | Non-homologous end-joining | 2.43E-03 | 1 | Q9NP87 | POLM | More | |
Vorapaxar | hsa04015 | Rap1 signaling pathway | 3.07E-02 | 4 | P25116, Q8TEU7, P08514, P17252 | F2R, RAPGEF6, ITGA2B, PRKCA | More | |
Vorapaxar | hsa04060 | Cytokine-cytokine receptor interaction | 1.71E-02 | 9 | P27930, P14778, P26842, Q13651, P25024, P09341, P18510, P09603, P01730 | IL1R2, IL1R1, CD27, IL10RA, CXCR1, CXCL1, IL1RN, CSF1, CD4 | More | |
Vorapaxar | hsa04064 | NF-kappa B signaling pathway | 4.09E-03 | 8 | P10415, O00463, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341 | BCL2, TRAF5, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1 | More | |
Vorapaxar | hsa04071 | Sphingolipid signaling pathway | 1.19E-02 | 5 | P21453, Q9H228, Q13362, Q9BX95, P10415 | S1PR1, EDG8, PPP2R5C, SGPP1, BCL2 | More | |
Vorapaxar | hsa04080 | Neuroactive ligand-receptor interaction | 1.00E-02 | 7 | P08311, Q15722, P21453, Q9H228, O00398, P21730, P07550 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, ADRB2 | More | |
Vorapaxar | hsa04140 | Autophagy - animal | 3.19E-02 | 4 | P22694, Q14643, P10415, Q04759 | PRKACB, ITPR1, BCL2, PRKCQ | More | |
Vorapaxar | hsa04141 | Protein processing in endoplasmic reticulum | 5.37E-04 | 4 | P30101, P60604, P11142, P08238 | PDIA3, UBE2G2, HSPA8, HSP90AB1 | More | |
Vorapaxar | hsa04145 | Phagosome | 4.48E-02 | 5 | Q15080, P05164, O60603, P35443, P13765 | NCF4, MPO, TLR2, THBS4, HLA-DOB | More | |
Vorapaxar | hsa04210 | Apoptosis | 3.44E-02 | 7 | Q13315, P10415, O76075, P24522, Q16548, P43234, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ITPR1 | More | |
Vorapaxar | hsa04340 | Hedgehog signaling pathway | 3.09E-02 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
Vorapaxar | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Vorapaxar | hsa04611 | Platelet activation | 3.39E-02 | 3 | P25116, P08514, P07359 | F2R, ITGA2B, GP1BA | More | |
Vorapaxar | hsa04612 | Antigen processing and presentation | 4.48E-02 | 5 | P13765, P26715, P26717, Q13241, P01732 | HLA-DOB, KLRC1, KLRC2, KLRD1, CD8A | More | |
Vorapaxar | hsa04613 | Neutrophil extracellular trap formation | 3.77E-03 | 12 | O60603, P05164, P08246, Q9UM07, Q93077, P62807, O60814, P68431, Q15080, P20160, P08311, P21730 | TLR2, MPO, ELA2, PADI4, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF4, AZU1, CTSG, C5AR1 | More | |
Vorapaxar | hsa04640 | Hematopoietic cell lineage | 7.16E-03 | 7 | P13612, P14778, P27930, P07766, P01730, P09564, P09603 | ITGA4, IL1R1, IL1R2, CD3E, CD4, CD7, CSF1 | More | |
Vorapaxar | hsa04650 | Natural killer cell mediated cytotoxicity | 2.96E-02 | 6 | O60880, P20963, Q13241, P26718, P26717, P26715 | SH2D1A, CD247, KLRD1, KLRK1, KLRC2, KLRC1 | More | |
Vorapaxar | hsa04658 | Th1 and Th2 cell differentiation | 1.51E-05 | 11 | Q04759, P07766, P20963, P09693, P01730, P06239, Q14765, P23771, Q9UL17, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, CD4, LCK, STAT4, GATA3, TBX21, HLA-DOB, RUNX3 | More | |
Vorapaxar | hsa04659 | Th17 cell differentiation | 7.88E-04 | 10 | Q04759, P01730, P06239, P13765, P14778, Q9UL17, P23771, P07766, P09693, P20963 | PRKCQ, CD4, LCK, HLA-DOB, IL1R1, TBX21, GATA3, CD3E, CD3G, CD247 | More | |
Vorapaxar | hsa04660 | T cell receptor signaling pathway | 1.00E-02 | 7 | Q9UDY8, Q04759, P10747, Q08881, P20963, P09693, P01732 | MALT1, PRKCQ, CD28, ITK, CD247, CD3G, CD8A | More | |
Vorapaxar | hsa04672 | Intestinal immune network for IgA production | 1.35E-02 | 2 | P29965, P13765 | CD40LG, HLA-DOB | More | |
Vorapaxar | hsa04724 | Glutamatergic synapse | 2.72E-03 | 5 | P48058, P43003, P63218, P50151, P15104 | GRIA4, SLC1A3, GNG5, GNG10, GLUL | More | |
Vorapaxar | hsa04727 | GABAergic synapse | 3.89E-02 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | |
Vorapaxar | hsa04730 | Long-term depression | 3.36E-04 | 2 | Q14344, P07948 | GNA13, LYN | More | |
Vorapaxar | hsa04918 | Thyroid hormone synthesis | 3.16E-02 | 2 | P17252, P27824 | PRKCA, CANX | More | |
Vorapaxar | hsa04922 | Glucagon signaling pathway | 4.23E-02 | 4 | P22694, P06737, Q12778, Q14643 | PRKACB, PYGL, FOXO1, ITPR1 | More | |
Vorapaxar | hsa04924 | Renin secretion | 1.04E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
Vorapaxar | hsa04928 | Parathyroid hormone synthesis, secretion and action | 4.23E-02 | 4 | Q14643, P22694, P23771, P10415 | ITPR1, PRKACB, GATA3, BCL2 | More | |
Vorapaxar | hsa05012 | Parkinson disease | 1.43E-03 | 4 | P21796, P60604, Q71U36, Q13509 | VDAC1, UBE2G2, TUBA1A, TUBB3 | More | |
Vorapaxar | hsa05020 | Prion disease | 3.23E-03 | 4 | P11142, P21796, Q71U36, Q13509 | HSPA8, VDAC1, TUBA1A, TUBB3 | More | |
Vorapaxar | hsa05022 | Pathways of neurodegeneration - multiple diseases | 4.84E-03 | 5 | Q71U36, Q13509, P21796, P04628, P60604 | TUBA1A, TUBB3, VDAC1, WNT1, UBE2G2 | More | |
Vorapaxar | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Vorapaxar | hsa05146 | Amoebiasis | 4.54E-03 | 6 | Q13751, P09341, P14778, P27930, P05089, P12814 | LAMB3, CXCL1, IL1R1, IL1R2, ARG1, ACTN1 | More | |
Vorapaxar | hsa05202 | Transcriptional misregulation in cancer | 2.90E-02 | 9 | Q12778, Q13315, P14780, Q16548, O15550, P05164, P08246, Q9C0K0, P24522 | FOXO1, ATM, MMP9, BCL2A1, UTX, MPO, ELA2, BCL11B, GADD45A | More | |
Vorapaxar | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
Vorapaxar | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Vorapaxar | hsa05205 | Proteoglycans in cancer | 4.46E-02 | 4 | Q12955, Q14247, P17252, P08962 | ANK3, CTTN, PRKCA, CD63 | More | |
Vorapaxar | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.84E-02 | 5 | P20963, P09693, O60603, P10747, Q04759 | CD247, CD3G, TLR2, CD28, PRKCQ | More | |
Vorapaxar | hsa05310 | Asthma | 1.35E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Vorapaxar | hsa05320 | Autoimmune thyroid disease | 3.16E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Vorapaxar | hsa05321 | Inflammatory bowel disease | 1.17E-03 | 5 | O60603, P13765, Q14765, Q9UL17, P23771 | TLR2, HLA-DOB, STAT4, TBX21, GATA3 | More | |
Vorapaxar | hsa05322 | Systemic lupus erythematosus | 1.31E-04 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Vorapaxar | hsa05323 | Rheumatoid arthritis | 1.60E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | |
Vorapaxar | hsa05330 | Allograft rejection | 3.16E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |
Vorapaxar | hsa05332 | Graft-versus-host disease | 3.45E-03 | 4 | P13765, P10747, P26715, Q13241 | HLA-DOB, CD28, KLRC1, KLRD1 | More | |
Vorapaxar | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 1.82E-02 | 3 | P14923, P08514, Q9UJU2 | JUP, ITGA2B, LEF1 | More | |
Vorapaxar | hsa05416 | Viral myocarditis | 4.29E-02 | 2 | P13765, P29965 | HLA-DOB, CD40LG | More | |